Avanza Fonder AB Buys Shares of 87,387 Colgate-Palmolive (NYSE:CL)

Avanza Fonder AB bought a new position in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 87,387 shares of the company’s stock, valued at approximately $7,944,000.

A number of other large investors also recently bought and sold shares of CL. State Street Corp lifted its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after buying an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in Colgate-Palmolive by 6.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after acquiring an additional 557,492 shares in the last quarter. Legal & General Group Plc boosted its holdings in Colgate-Palmolive by 0.8% during the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after acquiring an additional 61,413 shares during the period. Finally, Barclays PLC increased its stake in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.1 %

Shares of Colgate-Palmolive stock opened at $88.62 on Friday. The firm has a market cap of $72.40 billion, a PE ratio of 25.39, a P/E/G ratio of 3.01 and a beta of 0.44. The business’s fifty day moving average is $92.32 and its two-hundred day moving average is $97.85. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.26%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. UBS Group decreased their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday. JPMorgan Chase & Co. decreased their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. Finally, Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $102.11.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.